| Results summary | View all lists in GO:BiolProc | View all genes in S01BA.profile.ud50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.50-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 218502_S_AT | TRPS1 | T | D | R | trichorhinophalangeal syndrome I | ||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 206459_S_AT | WNT2B | D | S | wingless-type MMTV integration site family, member 2B | |||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 205116_AT | LAMA2 | D | C | laminin, alpha 2 (merosin, congenital muscular dystrophy) | |||||||||
| 217427_S_AT | HIRA | D | R | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | |||||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 207675_X_AT | ARTN | G | D | S | artemin | ||||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 219049_AT | CHGN | ||||||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
| 201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein | |||||